• CGA PS-54

CGA PS-54

  • CGA Position Statement on FDA Establishment Registration and Listing for Mixtures of Designated Medical Gases
  • Position Statement by Compressed Gas Association, 02/01/2018
  • Category: CGA

$3.00 $1.00

The U.S. Food and Drug Administration (FDA) drug registration and listing regulations, Title 21 of the U.S. Code of Federal Regulations (21 CFR) Part 207, do not address the unique properties of designated medical gas mixtures. Certain accommodations as presented in this position are made to conform with FDA?s requirements for electronic registration and listing submissions.
PDF

All of our standards document are available in PDF (Portable Document Format), an electronic, downloadable format.You will be able to download the file in your account downloads.

Multi-User Access

After purchasing, you have the ability to assign each license to a specific user.

Printable

At any time, you are permitted to make printed copies for your and your members' reference use.

CGA P-34

CGA P-34

Safe Handling of Ozone-Containing Mixtures Including the Installation and Operation of Ozone-Generat..

$19.00 $38.00

CGA M-12

CGA M-12

Investigating Out-of-Specification Test Results for Medical Gas Manufacturing, Second Edition..

$9.00 $17.00

CGA M-13

CGA M-13

Certifying Third-Party Testing Laboratories, Second Edition..

$16.00 $31.00

CGA P-48

CGA P-48

Reciprocating Cryogenic Pumps and Pump Installation, First Edition..

$29.00 $58.00